Conatus Pharmaceuticals Inc. (CNAT) financial statements (2021 and earlier)

Company profile

Business Address 10655 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:7214175773737
Cash and cash equivalents7211216581410
Other undisclosed cash, cash equivalents, and short-term investments  2959192327
Restricted cash and investments0      
Receivables0   3  
Inventory, net of allowances, customer advances and progress billings0      
Inventory0      
Prepaid expense1      
Other current assets0      
Other undisclosed current assets0174121
Total current assets:8224779803838
Noncurrent Assets
Operating lease, right-of-use asset4 
Property, plant and equipment0 00000
Other noncurrent assets2013210
Total noncurrent assets:7013211
TOTAL ASSETS:15224982824038
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:21612533
Accounts payable1      
Accrued liabilities2      
Employee-related liabilities 022211
Other undisclosed accounts payable and accrued liabilities 1410312
Deferred revenue0 
Debt00  1  
Deferred revenue and credits1431  
Contract with customer, liability10
Other undisclosed current liabilities0022211
Total current liabilities:3219284044
Noncurrent Liabilities
Long-term debt and lease obligation5  13 11
Long-term debt, excluding current maturities   13 11
Operating lease, liability5 
Liabilities, other than long-term debt0 3132100
Deferred revenue and credits132100
Deferred revenue0 
Contract with customer, liability3
Deferred rent credit  0
Other liabilities0      
Other undisclosed noncurrent liabilities0      
Total noncurrent liabilities:5 3262111
Total liabilities:8221546155
Stockholders' equity
Stockholders' equity attributable to parent8202728223533
Common stock0000000
Additional paid in capital71218214196172155130
Accumulated other comprehensive loss  (0)(0)(0)(0)(0)
Accumulated deficit(63)(198)(187)(168)(151)(121)(97)
Stockholders' equity attributable to noncontrolling interest(1)      
Total stockholders' equity:7202728223533
TOTAL LIABILITIES AND EQUITY:15224982824038

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues22234351  
Cost of revenue
(Cost of Goods and Services Sold)
(0)      
Gross profit:22234351  
Operating expenses(21)(34)(52)(53)(31)(24)(22)
Other undisclosed operating income0      
Operating loss:(19)(12)(18)(18)(30)(24)(22)
Nonoperating income (expense)01000(0)(0)
Investment income, nonoperating(0)11100(1)
Other nonoperating income (expense)000(0)0(0)(0)
Interest and debt expense(0) (1)(1)(0)(0)(0)
Loss before gain (loss) on sale of properties:(19)(11)(19)(18)(30)(24)(22)
Other undisclosed net income0 1    
Net loss:(19)(11)(18)(18)(30)(24)(22)
Net income attributable to noncontrolling interest0      
Other undisclosed net income attributable to parent   1000
Net loss available to common stockholders, diluted:(19)(11)(18)(17)(30)(24)(22)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(19)(11)(18)(18)(30)(24)(22)
Comprehensive loss:(19)(11)(18)(18)(30)(24)(22)
Comprehensive income, net of tax, attributable to noncontrolling interest0      
Other undisclosed comprehensive income, net of tax, attributable to parent 001000
Comprehensive loss, net of tax, attributable to parent:(19)(11)(18)(17)(30)(24)(22)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: